Mineralocorticoid receptor agonist; corticosteroid
This page covers all Mineralocorticoid receptor agonist; corticosteroid drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Mineralocorticoid receptor (MR).
Targets
Mineralocorticoid receptor (MR)
Marketed (1)
- Fludrocortisone/ Fludrocortisone acetate · Merck Sharp & Dohme LLC · Endocrinology; Cardiovascular
Fludrocortisone is a synthetic corticosteroid that acts as a mineralocorticoid receptor agonist, increasing sodium reabsorption and potassium excretion in the kidneys to regulate fluid and electrolyte balance.
Phase 3 pipeline (1)
- Fludrocortisone Acetate Tablets · Tehran Heart Center · Endocrinology / Cardiovascular
Fludrocortisone acetate is a synthetic mineralocorticoid that enhances sodium reabsorption and potassium excretion in the distal renal tubules, thereby increasing blood volume and blood pressure.
Patent intelligence
- mineralocorticoid receptor agonist patent landscape — aggregated cliff calendar, attackable patents, originator estates